AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$26.93
+2.28%Forward multiples
Based on analyst estimates
- P/E forward
- 8.36x
- P/E 2026E
- 9.05x
- P/E 2027E
- 8.45x
- P/E 2028E
- 7.97x
- P/S forward
- 1.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.48x
- PEG TTM
- 0.18x
- Price / book
- 1.49x
- Price / sales
- 1.57x
- Price / cash flow
- 6.21x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 2.11x
- EV / EBITDA
- 8.07x
- EV / EBIT
- 13.51x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026